Marijuana, e-cigarette, and tobacco product use in young adults who underwent pediatric bariatric surgery.

Autor: Zeller MH; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: meg.zeller@cchmc.org., Strong H; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Reiter-Purtill J; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Jenkins TM; Division of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Mitchell JE; Department of Psychiatry and Behavioral Science, University of North Dakota, Fargo, North Dakota., Michalsky MP; Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio., Helmrath MA; Division of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Jazyk: angličtina
Zdroj: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery [Surg Obes Relat Dis] 2023 May; Vol. 19 (5), pp. 512-521. Date of Electronic Publication: 2022 Nov 19.
DOI: 10.1016/j.soard.2022.11.008
Abstrakt: Background: The postoperative course after pediatric metabolic and bariatric surgery (MBS) cuts across a developmental phase when substance-use behaviors emerge as significant public health concerns.
Objective: We examined use of marijuana, conventional cigarettes, and alternate tobacco products/devices (e.g., e-cigarettes, hookah, smokeless, dissolvable) in young adults (YA) to 6 years postsurgery.
Setting: Five academic medical centers.
Methods: In a prospective observational cohort series, 139 surgical (M age = 16.9, M body mass index [BMI] = 51.5, 80% female, 66% white) and 83 nonsurgical comparisons (M age = 16.1, M BMI = 44.9, 82% female, 54% white) completed assessments at presurgery/baseline and postsurgery years 2, 4, and 6 (year 6 [2014-2018]: surgical n = 123 [89%], M age = 23.0, M BMI = 39.8; nonsurgical n = 63 [76%], M age = 22.4, M BMI = 53.6). Lifetime and current (past 30 days) use were reported.
Results: Consistent with national YA trends (2014-2018), the most commonly used were (1) conventional cigarettes (30% surgical, 41% nonsurgical, nonsignificant [ns]); (2) marijuana (25% surgical, 27% nonsurgical, ns); and (3) e-cigarettes (12% surgical, 10% nonsurgical). A sizable minority (26% surgical, 18% nonsurgical) used one or more alternate tobacco product/device. Many YA reported persistent and/or heavy use (e.g., >50% marijuana at year 6 and year 2 or 4; ≈50% ≥.5 pack/d of cigarettes), suggesting more established (versus intermittent) health risk behaviors. For the surgical group at year 6, current tobacco product/device use was associated with lower BMI (P < .001) and greater percent weight loss (P = .002).
Conclusions: Pediatric MBS demonstrates promise in lowering risks for adult chronic disease, which may be diminished by age-typical health risk behaviors. Developmentally salient and holistic pediatric postoperative care guidelines are needed.
(Copyright © 2022 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: